Lecanemab (BAN2401): an anti–beta-amyloid monoclonal antibody for the treatment of Alzheimer disease

单克隆抗体 临床试验 医学 淀粉样蛋白(真菌学) 人源化抗体 药理学 抗体 单克隆 神经科学 免疫学 生物 病理
作者
Grace Vitek,Boris Decourt,Marwan N. Sabbagh
出处
期刊:Expert Opinion on Investigational Drugs [Taylor & Francis]
卷期号:32 (2): 89-94 被引量:59
标识
DOI:10.1080/13543784.2023.2178414
摘要

Introduction Nearly a dozen monoclonal antibodies (mAbs) directed against beta-amyloid (Aβ) have been developed for the treatment of Alzheimer disease (AD), and most of these mAbs are undergoing clinical trials. Newer mAbs have targeted more specific Aβ types. Lecanemab Eisai has a high affinity for large and soluble Aβ protofibrils. Data from phase 2 clinical trials have suggested the possibility of a robust efficacy signal and manageable risk of amyloid-related imaging abnormalities (ARIAs). Lecanemab is currently being studied in phase 3 trials.Areas covered This article briefly reviews mAbs that target Aβ in AD and discusses the biology, mechanism of action, and targets of lecanemab.Expert opinion mAbs that target Aβ are an important focus of therapeutic development for AD, with several soon to be considered for US Food and Drug Administration approval. The experience of aducanumab informs the development of other mAbs, such as lecanemab. One consideration is the conformation of Aβ targets. Targeting monomeric species has not resulted in robust clinical efficacy, whereas targeting Aβ in the form of oligomers, protofibrils, and plaques has shown evidence of slowing clinical decline. Another consideration is that mAbs will require safety monitoring for ARIAs.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
123关闭了123文献求助
2秒前
HY发布了新的文献求助10
2秒前
Jasper应助Micah采纳,获得10
3秒前
ll完成签到 ,获得积分10
5秒前
YYB65完成签到,获得积分10
5秒前
香蕉觅云应助飞快的稚晴采纳,获得10
6秒前
顺心向松完成签到,获得积分10
6秒前
7秒前
方法发布了新的文献求助10
7秒前
小白完成签到,获得积分10
10秒前
科隆龙完成签到,获得积分10
14秒前
DAYTOY完成签到,获得积分10
16秒前
zx完成签到,获得积分20
17秒前
在水一方应助方法采纳,获得10
17秒前
Ava应助孙成成采纳,获得30
18秒前
凡迪亚比应助lena采纳,获得10
21秒前
22秒前
22秒前
香蕉觅云应助zcy采纳,获得10
24秒前
NexusExplorer应助科研通管家采纳,获得10
25秒前
田様应助科研通管家采纳,获得10
25秒前
未命名应助科研通管家采纳,获得20
25秒前
lant0932应助科研通管家采纳,获得10
25秒前
Lyla应助科研通管家采纳,获得10
25秒前
俏皮诺言发布了新的文献求助10
25秒前
JamesPei应助科研通管家采纳,获得10
26秒前
无花果应助科研通管家采纳,获得10
26秒前
传奇3应助科研通管家采纳,获得10
26秒前
AGuang应助科研通管家采纳,获得10
26秒前
Ava应助科研通管家采纳,获得10
26秒前
大模型应助科研通管家采纳,获得10
26秒前
领导范儿应助科研通管家采纳,获得10
26秒前
桐桐应助科研通管家采纳,获得30
26秒前
逸之狐应助科研通管家采纳,获得20
26秒前
香蕉觅云应助科研通管家采纳,获得10
26秒前
27秒前
31秒前
seal发布了新的文献求助10
33秒前
myduty完成签到 ,获得积分10
33秒前
高分求助中
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Cognitive Neuroscience: The Biology of the Mind (Sixth Edition) 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
Christian Women in Chinese Society: The Anglican Story 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3961083
求助须知:如何正确求助?哪些是违规求助? 3507362
关于积分的说明 11135734
捐赠科研通 3239863
什么是DOI,文献DOI怎么找? 1790434
邀请新用户注册赠送积分活动 872400
科研通“疑难数据库(出版商)”最低求助积分说明 803150